AUS
NZ
UK
CA
USA
IND
Healthcare
Tryptamine Therapeutics Completes First Dosing in Obesity Study for Psilocin-Based Treatment
November 22, 2024 04:50 PM AEDT| By Team Kalkine MediaHighlights,Clinical Progress:,First subject dosed in a Phase 1b study evaluating TRP-8803 in obese participants.,Study Goals:,Aims to assess pharmacokinetic differences compared to non-obese patients.,Advancing to Phase 2:,Data will optimize dosing f...
Alcidion Secures Major Deal with Peninsula Health for Miya Precision Platform
November 22, 2024 03:51 PM AEDT| By Team Kalkine MediaHighlights,Alcidion,signs a five-year contract with Peninsula Health.,Miya Precision platform to enhance patient data management and hospital operations.,Advanced technology aims to reduce administrative workload on hospital staff.,Alcidion (ASX:ALC)...
Healthscope Cancels Bupa Deal, Increasing Costs for Millions
November 22, 2024 12:22 PM AEDT| By Team Kalkine MediaHighlights:,Termination of Healthscope-Bupa Agreement:,Healthscope (,ASX:HSO,) has,terminated,its agreement with Bupa and other not-for-profit insurers, affecting 6.5 million Australians who may face higher medical costs starting February 1.,Financia...
Millions of Australians Face Loss of Coverage at 38 Private Hospitals
November 22, 2024 12:14 PM AEDT| By Team Kalkine MediaHighlights:,Coverage Termination,:,Over 6 million Australians are set to lose coverage at 38 private hospitals due to Healthscope's withdrawal from agreements with major health insurers, including Bupa and AHSA.,Financial Dispute,:,The move highlight...
Tryptamine Therapeutics (ASX:TYP) Advances Obesity-Focused Psilocin Study
November 22, 2024 11:36 AM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics administers TRP-8803 to the first obese participant in a Phase 1b study.,Study explores pharmacokinetics differences between obese and non-obese participants.,Interim results expected this year to inform future tria...
Race Oncology (ASX:RAC) Advances FTO Drug Discovery
November 22, 2024 11:34 AM AEDT| By Team Kalkine MediaHighlights,Discovery of 39 molecular candidates targeting the m6A RNA demethylase protein.,Findings,validated,using advanced NMR spectroscopy and resonance techniques.,Innovative drug discovery approach,leveraging,RNA epigenetics for disease treatmen...
Algorae Pharma Advances Drug Development with AlgoraeOS
November 21, 2024 04:39 PM AEDT| By Team Kalkine MediaHighlights,Algorae,Pharmaceuticals,identifies,24 new drug targets using AI,.,Preclinical studies to assess targets for oncology treatments,.,Expansion of AI-powered drug platform to Version 2.0 announced,.,Algorae Pharmaceuticals (ASX:1AI) has unveil...
Knosys Secures Two-Year Contract Extension with Healthdirect
November 21, 2024 04:21 PM AEDT| By Team Kalkine MediaHighlights,Knosys extends SaaS contract with,Healthdirect,until 2027,.,KnowledgeIQ,continues as a core tool in healthcare and beyond,.,Shares of Knosys show growth over the past year,.,Knosys (ASX:KNO), a leading provider of knowledge management solu...
Race Oncology Identifies 39 FTO Inhibitors for Cancer Therapy
November 21, 2024 04:18 PM AEDT| By Team Kalkine MediaHighlights,Race Oncology discovers 39 molecules targeting cancer-linked proteins,.,Focus on FTO inhibition, key in cancer RNA regulation,.,Collaboration with Monash University boosts oncology research,.,Race Oncology (ASX:RAC) has successfully comple...
Race Oncology’s FTO Breakthrough: Pioneering RNA Epigenetics for New Drugs
November 21, 2024 12:58 PM AEDT| By Team Kalkine MediaHighlights,Race Oncology discovers unique FTO inhibitors in RNA epigenetics research,.,Program,identifies,39 molecular candidates with potential for patentable drugs,.,Novel inhibitors target m6A RNA pathway, expanding applications beyond cancer ther...
PainChek Targets FDA Approval for Its Adult App Expansion
November 20, 2024 02:30 PM AEDT| By Team Kalkine MediaHighlights,PainChek,has applied for FDA De Novo approval for its Adult App.,US-based validation study completion supports the application.,Partnerships in North America to accelerate market entry.,PainChek (ASX:PCK) has made a significant move in its...
Singular Health Partners with Miami Clinic for 3D Imaging Breakthrough
November 20, 2024 01:34 PM AEDT| By Team Kalkine MediaHighlights,Singular Health announces partnership with Miami-based health clinic,.,Focus on advancing its 3Dicom technology through a commercial pilot,.,Partnership includes A$500,000 equity investment from Provider Network Solutions (PNS),.,Singular...
Biotron Limited Rolls Out New Shares on ASX
November 19, 2024 04:52 PM AEDT| By Team Kalkine MediaHighlights:,Biotron Limited issued 20,751 fully paid ordinary shares on the ASX.,The share issuance results from the exercise of options and conversion of convertible securities.,The move marks a significant step in Biotron's ongoing capital manageme...
Sonic Healthcare Ltd (ASX: SHL) Up 4% After AGM Update
November 19, 2024 01:18 PM AEDT| By Team Kalkine MediaHighlights:,Sonic Healthcare (ASX: SHL) shares rise 4% to $27.30 after providing key updates during its AGM.,The company reported $9 billion in FY24 revenue, with non-COVID-related sales up 16%.,Sonic also raised its dividend by 2%, reflecting strong...
Tryptamine Therapeutics Readies Phase 2 Trials for Psilocin Therapy
November 19, 2024 12:40 PM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics progresses to Phase 2 clinical trials for TRP-8803,.,TRP-8803,demonstrated,enhanced safety and efficiency in Phase 1b studies,.,The IV-infusion formulation offers key advantages over traditional oral dosing,.,Trypta...
CSL Shares Shed 10% in a Month: Market Disruption a Possible Factor
November 18, 2024 06:31 PM AEDT| By Team Kalkine MediaHighlights:,CSL Ltd shares have experienced a 9.77% decline over the past month.,The drop in CSL shares aligns with broader selloffs in the healthcare sector, influenced by geopolitical and regulatory concerns.,Despite the decline, CSL has reaffirmed...
CSL Shares Dip Amid Concerns Over RFK Jr’s Vaccine Policies
November 18, 2024 04:07 PM AEDT| By Team Kalkine MediaHighlights,C,SL falls to a six-month low amid vaccine policy uncertainty,.,Broader ASX healthcare sector declines following the nomination,.,Potential impacts on biotechnology and vaccine manufacturers highlighted,.,Australia's leading pharmaceutical...
Amplia Therapeutics Teams Up with Next&Bio for Preclinical Research on Pancreatic Cancer
November 18, 2024 03:14 PM AEDT| By Team Kalkine MediaHighlights,Amplia,Therapeutics partners with,Next&Bio,to evaluate the impact of FAK inhibitors on pancreatic cancer,.,The study explores potential,synergy,between,Amplia’s,AMP945 and emerging,kRas,inhibitors,.,Next&Bio,uses advanced patient-derived m...
Radiopharm Theranostics Boosts Prospects with Pancreatic Cancer Imaging Study
November 18, 2024 12:10 PM AEDT| By Team Kalkine MediaHighlights,Radiopharm,Theranostics,’ imaging drug RAD 301 shows promising results for pancreatic cancer detection,.,A published study supports its ability to distinguish primary carcinoma and metastases effectively,.,RAD 301 achieves a high tumor-to-...
InhaleRX (ASX:IRX) Gains Phase 2 Approval for Non-Opioid Cancer Pain Therapy
November 15, 2024 02:54 PM AEDT| By Team Kalkine MediaHighlights,InhaleRX,receives approval for Phase 2 trial to explore non-opioid cancer pain therapy.,IRX-211 aims to offer a safe, fast-acting pain relief alternative for cancer patients.,Non-opioid breakthrough could address a significant market deman...
Advertise your brand on Kalkine Media